Cite
Post-Treatment Prostate-Specific Antigen Nadir is Predictive of All-Cause Mortality: A Reanalysis of the Dana Farber Cancer Institute Radiation With or Without Androgen Deprivation Therapy Randomized Trial
MLA
Tseng, Y. D., et al. “Post-Treatment Prostate-Specific Antigen Nadir Is Predictive of All-Cause Mortality: A Reanalysis of the Dana Farber Cancer Institute Radiation With or Without Androgen Deprivation Therapy Randomized Trial.” International Journal of Radiation Oncology, Biology, Physics, vol. 81, no. 2, Oct. 2011, pp. S417–18. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2011.06.681.
APA
Tseng, Y. D., Chen, M., Loffredo, M., Kantoff, P. W., Beard, C. J., Martin, N. E., Orio, P. F., D’Amico, A. V., & Nguyen, P. L. (2011). Post-Treatment Prostate-Specific Antigen Nadir is Predictive of All-Cause Mortality: A Reanalysis of the Dana Farber Cancer Institute Radiation With or Without Androgen Deprivation Therapy Randomized Trial. International Journal of Radiation Oncology, Biology, Physics, 81(2), S417–S418. https://doi.org/10.1016/j.ijrobp.2011.06.681
Chicago
Tseng, Y.D., M. Chen, M. Loffredo, P.W. Kantoff, C.J. Beard, N.E. Martin, P.F. Orio, A.V. D’Amico, and P.L. Nguyen. 2011. “Post-Treatment Prostate-Specific Antigen Nadir Is Predictive of All-Cause Mortality: A Reanalysis of the Dana Farber Cancer Institute Radiation With or Without Androgen Deprivation Therapy Randomized Trial.” International Journal of Radiation Oncology, Biology, Physics 81 (2): S417–18. doi:10.1016/j.ijrobp.2011.06.681.